NM_000297.4(PKD2):c.1395T>A (p.Tyr465Ter) AND Polycystic kidney disease 2
- Germline classification:
- Pathogenic (1 submission)
- Last evaluated:
- Dec 3, 2021
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV003991132.2
Allele description [Variation Report for NM_000297.4(PKD2):c.1395T>A (p.Tyr465Ter)]
NM_000297.4(PKD2):c.1395T>A (p.Tyr465Ter)
Condition(s)
-
List of abbreviations - Adalimumab in combination with methotrexate for refracto...
List of abbreviations - Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT
-
Clinical effectiveness results: open-label phase - Adalimumab in combination wit...
Clinical effectiveness results: open-label phase - Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT
-
Gm37210 AND (alive[prop]) (0)
Gene
-
LOC101973161 [Ictidomys tridecemlineatus]
LOC101973161 [Ictidomys tridecemlineatus]Gene ID:101973161Gene
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Jun 2, 2024